This session will dive into how healthcare data, when combined with AI, is poised to reshape the future of medicine, with a focus on data veracity and training large language models (LLMs). As Bill Gates recently noted, “the biggest revolution through AI will be in education and healthcare.” You’ll explore how accurate data fuels AI’s potential for groundbreaking healthcare innovations, how effectiveness gets a boost, how staff shortage will be overcome, and how overall costs will shrink. Whether you’re a family office principal, founder, or VC, this workshop will provide critical insights into the intersection of AI and healthcare data – a space where transformative change is happening right now. Don’t miss this opportunity to learn from industry leaders and capitalize on new growth and impact in this rapidly evolving field. 

ACP Healthtech Fund, managed by Aescuvest Capital Partners, is an investment vehicle focused on transformative healthtech innovations. The fund targets high-growth opportunities at the intersection of healthcare and technology, particularly pre-regulatory approval companies poised to make significant strides in personalized diagnostics and preventive care. By strategically investing in companies nearing critical regulatory milestones, ACP ensures both a high potential for financial returns and a meaningful impact on patient outcomes. The fund’s disciplined approach and proven track record of success offer investors a unique chance to capitalize on the next generation of healthcare breakthroughs, delivering substantial value while advancing global healthcare.

Dr. Patrick Pfeffer

Private Wealth Holder, General Partner ACP Healthtech | CEO Aescuvest

Dr. Patrick Pfeffer operates the largest network of family offices investing in healthcare across Europe and Turkey. After ea rning his PhD in machine learning, he had a successful career in pharma, including serving as Managing Director of WebMD’s Medscape platform in Europe, where he was an integral part of preparing the company for its multi-billion-dollar exit to KKR. Today, as the Founder and Managing Partner at ACP Healthtech, he leads efforts to transform healthcare from reactive “sickcare” to proactive solutions.

His strategic vision focuses on healthtech innovations that enhance patient outcomes while offering significant financial returns, creating opportunities for investors to drive impactful growth in the future of healthcare.